Biochemistry and Molecular Biology
PhD
Queen Mary and Westfield College- University of London, UK
1997
See all Profiles
Faculty
Faculty
Bernard Kwabi-Addo, PHD (He)
Associate Professor
Department/Office
- Biochemistry
School/College
- College of Medicine
Biography
I am a Professor of Biochemistry and Molecular Biology and also a Principal Investigator of Prostate Cancer Research at Howard University, in Washington D.C. My research interests are: Molecular Biology/ biochemistry: Cancer Health Disparities, Signal Transduction, Gene Expression and Regulation, Epigenetic DNA methylation studies and Prostate Cancer Research. The focus on my current research activity is to elucidate aberrant epigenetic alterations that underlies prostate cancer etiology and the disease aggression, a disease that disproportionately impact men of African Ancestry. The ultimate goal of my research work is to identify novel epigenome-derived markers that can be used either alone or in conjunction with current molecular markers for screening and diagnosing prostate cancer disparity. I am also interested in understanding the social determinants and environmental factors and how these impact the genome to drive not only prostate cancer but cancer in general and cancer disparities. I give didactic lectures on various biochemistry and molecular biology topics to medical, dental and graduate students at Howard University. In my spare time, I educate local communities and church settings on topics of cancer prevention and the importance of adhering to the recommended age-appropriate screening as well as the importance of healthy dietary patterns, avoidance of sedentary lifestyle and the adoption of healthy behavior and lifestyle patterns to avoid and even reverse or eliminate chronic diseases.
Education & Expertise
Education
Expertise
Cancer Research, Health Disparities, Cancer Prevention, Translational Studies, Biomarker Development
I am an Associate Professor of Biochemistry and Molecular Biology and a Principal Investigator of Prostate Cancer Research at Howard University Cancer Center. I have expertise in biochemical and molecular biology skills relevant fcto ncer research and health disparities. The current focus on my research laboratory is to elucidate aberrant global and loci-specific epigenetic alterations associated with aggressive prostate cancer in African American men. The goal of my laboratory is to identify novel epigenetic-based biomarkers for cancer detection and to explore epigenetic alterations in cancer for novel therapuetic angles.
Academics
Academics
Molecules and Cells Unit 1- Medical Course for Medical Students.
Biochemistry and Molecular Biology courses to Dentistry students
Biochemistry and Molecular Biology courses to graduate students
I give didactic lectures in Blood Coagulation, Hormonal signals, Cancer topics and other lectures in Biochemistry and Molecular Biology to Medical, Dental and graduate students.
Research
Research
Specialty
Prostate Cancer and Prostate Cancer Disparities researchFunding
- Role Project PI- Bernard Kwabi-Addo PhD (Southerland W- RCMI Director; PI- Howard University).
Grant Period: 07/01/2019- 06/30/2024
Title: Epigenetic Regulated Genes in African-American Prostate Cancer Patients.
Grant Mechanism: National Institute of Minority Health and Health Disparities
U54 MD007579 (RCMI).
Group Information
Dr. Krishma Tailor (post-doctoral researcher)
Accomplishments
Accomplishments
• 1993- 1997Medical Research Council PhD Scholarship Award Nov. 2004 American Association for Cancer Research Minority Scholar Award • April 2008 American Association for Cancer Research Minority- Serving Institution Faculty Scholar Award • Feb. 2010
1993- 1997 Medical Research Council PhD Scholarship AwardNov. 2004 American Association for Cancer Research Minoritycholar AwardApril 2008 American Association for Cancer Research Minority- Serving Institution Faculty Scholar AwardFeb. 2010 American Association for Cancer Research Minority- Serving Institution Faculty Scholar AwardApril 2010 Howard University College of Medicine Research Day Abstract Competition- 3rd Place Travel Award (Junior Faculty)December 2012 Travel Award, 13th RCMI International Symposium on Health DisparitiesApril 2014 American Association for Cancer Research Minority- Serving Institution Faculty Scholar Award
Related Articles
Complete list of my published work can be found online https://www.researchgate.net/profile/Bernard_KwabiAddo.
1. Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, RabbittsP. A site-directed chromosomal translocation induced in embryonic stem cells byCre-loxP recombination. Nat. Genet. 1995; 9:376-85.2. Kwabi-Addo B, Thompson TC, Ittmann M. Absence of PTEN/MMAC1 pseudogene in mice. DNA Cell Biol. 2000; 19: 301-5. 3. Ropiquet F, Giri D, Kwabi-Addo B, Mansukhani A, Ittmann M. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 2000; 60: 4245-50.4. Ropiquet F, Giri D, Kwabi-Addo B, Schmidt K, Ittmann M. FGF-10 is expressed at low levels in the human prostate. Prostate. 2000; 44:334-8.5. Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M. Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate. 2001; 46: 163-72.6. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parson R, Greenberg N, Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc. Natl. Acad. Sci U.S.A. 2001; 98: 11563-8.7. Shan L, Chen GL. Chengxi R, Kwabi-Addo B, Epner DE. Methionine restriction selectivity targets thymidylate synthase in prostate cancer cells. Biochemical Pharmacology. 2003; 66:791-800.8. Polnaszek N, Kwabi-Addo B, Peterson L, Ozen M, Greenberg N, Ortega S, Basilico C, Ittmann M. FGF2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res 2003; 63: 5754-5760.9. Polnaszek N, Kwabi-Addo B, Wang J, Ittmann M. FGF17 is an autocrine prostatatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Prostate. 2004; 60: 18-24.10. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M.Sprouty1, an inhibitor of Fibroblast growth factors is down-regulated in prostate cancer. Cancer Res. 2004; 64: 4728-35.11. Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer. 2004; 11: 709-24.12. Rosa A.L., Wu Y., Kwabi-Addo B, Coveler K. J., Sutton V. R., Shaffer L. G.Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32. Chromosome Res. 2005; 13:809-18.13. Wang J, Luo H, Thompson B, Ren C, Ittmann M, Kwabi-Addo B. Sprouty4 is a suppressor of tumor cell motility that is methylated in human prostate cancer. Prostate. 2006; 66:613-24.14. Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007; 13:1695-702.15. Bernard Kwabi-Addo, Woonbok Chung, Lanlan Shen, Michael Ittmann, Thomas Wheeler, Jaroslav Jelinek and Jean-Pierre J. Issa. Age-Related DNA Methylation Changes in Normal Human Prostate Tissues. Clin Cancer Res. 2007;13:3796-3802.16. Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, Issa JP.Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS ONE. 2008; 3: e2079.17. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008; 40:741-50.18. Kwabi-Addo B, Ren C, Ittmann M. DNA methylation and aberrant expression of sprouty1 in human prostate cancer. Epigenetics. 2009; 4: 54-61. 19. Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin. Cancer Res. 2010; 16:3539-47.20. Darimipourain M, Wang S, Ittmann M, Kwabi-Addo B. Transcriptional and post- transcriptional regulation of Sprouty1, a Receptor Tyrosine Kinase Inhibitor in Prostate Cancer. Prostate Cancer and Prostatic diseases. 2011; 14: 279-85.21. Vaughn MP, Biswal Shinohara D, Castagna N, Hicks JL, Netto G, De Marzo AM, Speed TJ, Reichert ZR, Kwabi-Addo B, Henderson CJ, Wolf CR, Yegnasubramanian S, Nelson WG. Humanizing π-Class Glutathione S- Transferase Regulation in a Mouse Model Alters Liver Toxicity in Response to Acetaminophen Overdose. PLoS ONE. 2011; 6: e25707.22. Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B.Relationship between Tumor DNA Methylation Status and Patient Characteristics in African-American and European-American Women with Breast Cancer. PLoS ONE. 2012; 7:e37928.23. Akinboye ES, Rosen MD, Denmeade SR, Kwabi-Addo B, Bakare O. Design, synthesis and evaluation of pH-dependent hydrolysable emetine analogs as treatment for prostate cancer. J Med Chem. 2012; 55:7450-9.24. Devaney JM, Funda S, Long J, Taghipour DJ, Tbaishat R, Furbert-Harris P, Wang S, Ittmann M, Kwabi-Addo B. Identification of Novel DNA Methylation Biomarkers Associated with Human Prostate Cancer and High Grade Prostatic Intraepithelial Neoplasia. Prostate Cancer and Prostatic Diseases 2013; 16:292-300.25. Wing MR, Devaney JM, Joffe MM, Xie D, Feldman HI, Dominic EA, Guzman NJ, Ramezani A, Susztak K, Herman JG, Cope L, Harmon B, Kwabi-Addo B, Go AS, He J, Lash JP, Kusek JW and Raj DS. DNA Methylation Profile Associated with Rapid Decline in Kidney Function: Findings from the CRIC Study. Nephrol Dial Transplant. 2014; 29:864-72.26. Devaney JM, Wang S, Furbert-Harris P, Apprey V, Ittmann M, Wang BD, Olender J, Lee NH, Kwabi-Addo B. Genome-wide differentially methylated genes in prostate tissues from African-American and Caucasian men. Epigenetics2015; 10(4): 319-28.27. Akinboye ES, Bamji ZD, Kwabi-Addo B, Ejeh D, Copeland RL, Denmeade SR, Bakare O. Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines. Bioorg Med Chem. 2015;23(17: 5839-45.28. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer. Wang S, Clark PA, Davis R, Mumunui S, Kwabi-Addo B (2016); 86: 110-118.29. Correlating Blood-Based DNA Methylation Markers and Prostate Cancer Risk in African-American men. Moses-Fynn E , Tang W, Beyene D, Apprey V, Copeland R, Kanaan Y, Kwabi-Addo B. PLoS One. 2018 Sep 11;13(9):e0203322. 30. Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity Apprey V, Wang S, Tang W, Kittles RA, Southerland WM, Ittmann M, Kwabi-Addo B. Anticancer Res. 2019 Nov;39(11):5861-5866. 31. Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells. Songping Wang , Krishma Tailor , Bernard Kwabi-Addo. Anticancer Res 2020 May;40(5):2559-2565.32. Interactions Between Obesity and One-Carbon Metabolism Genes in Predicting Prostate Cancer Outcomes Among White and Black Patients. Scott W Keith, Bernard Kwabi-Addo, Charnita Zeigler-Johnson. J Racial Ethn Health Disparities. 2021 Jan 11. doi: 10.1007/s40615-020-00958-6. Online ahead of print.